Results 241 to 250 of about 171,941 (345)
Minimal residual disease and relapse surveillance in osteosarcoma: an action-linked framework integrating liquid biopsy and imaging biomarkers. [PDF]
Huang G, Zhou Y, Wang H, Ma X.
europepmc +1 more source
Idiculla, Jose Joy +2 more
openaire +3 more sources
ABSTRACT Companion canines need advances in therapeutic options for solid tumour malignancies. Natural killer (NK) cell infusions offer a promising treatment modality in canines with solid tumours. Autologous natural killer products are limited by dysfunctional immunity and a manufacturing process that delays care whereas allogeneic NK cells offer the ...
Allison M. Weisnicht +11 more
wiley +1 more source
Gene expression of neurochemical stress and protumor markers in osteosarcoma, adjacent tissue, and healthy bone [PDF]
Cindy Bandala +5 more
openalex +1 more source
ABSTRACT DNA mismatch repair (MMR) deficiency is a clinically important biomarker in human oncology, yet its relevance in feline neoplasia remains poorly understood due to limited characterisation and the absence of validated reagents. In this study, we established a practical immunohistochemistry (IHC) approach for evaluating feline MMR proteins by ...
Shoma Nishibori +7 more
wiley +1 more source
Application of CAR-T cell therapy in orthopedics: From bone malignancies to non-malignant musculoskeletal disorders. [PDF]
Que Y +7 more
europepmc +1 more source
ABSTRACT Although osteosarcoma is the most common primary bone tumour in dogs, involvement of the pelvic bones is rare. The aim of the present study was to describe clinical presentation, identify possible prognostic factors, and evaluate outcomes in dogs diagnosed with pelvic osteosarcoma.
Csilla Fejös +15 more
wiley +1 more source

